Stam CJ. Modern network science of neurological disorders. Nat Rev Neurosci. 2014;15:683–95.

Article  PubMed  Google Scholar 

Ryan TJ, Grant SGN. The origin and evolution of synapses. Nat Rev Neurosci. 2009;10:701–12.

Article  PubMed  Google Scholar 

Alex F, Andrew Z, Edward B. Fundamentals of brain network analysis. Academic; 2016.

Cohen-Cory S. The developing synapse: construction and modulation of synaptic structures and circuits. Science. 2002;298:770–6.

Article  PubMed  Google Scholar 

Staley K. Molecular mechanisms of epilepsy. Nat Neurosci. 2015;18:367–72.

Article  PubMed  PubMed Central  Google Scholar 

Uezu A, Kanak DJ, Bradshaw TWA, Soderblom EJ, Catavero CM, Burette AC, et al. Identification of an elaborate complex mediating postsynaptic inhibition. Science. 2016;353:1123–9.

Article  PubMed  PubMed Central  Google Scholar 

Casillas-Espinosa PM, Powell KL, O’Brien TJ. Regulators of synaptic transmission: roles in the pathogenesis and treatment of epilepsy. Epilepsia. 2012;53(Suppl 9):41–58.

Article  PubMed  Google Scholar 

Bajjalieh SM, Frantz GD, Weimann JM, McConnell SK, Scheller RH. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci. 1994;14:5223–35.

Article  PubMed  PubMed Central  Google Scholar 

Stout KA, Dunn AR, Hoffman C, Miller GW. The synaptic vesicle glycoprotein 2: structure, function, and Disease Relevance. ACS Chem Neurosci. 2019;10:3927–38.

Article  PubMed  Google Scholar 

Mendoza-Torreblanca JG, Vanoye-Carlo A, Phillips-Farfán BV, Carmona-Aparicio L, Gómez-Lira G. Synaptic vesicle protein 2A: basic facts and role in synaptic function. Eur J Neurosci. 2013;38:3529–39.

Article  PubMed  Google Scholar 

van Vliet EA, Aronica E, Redeker S, Boer K, Gorter JA. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia. 2009;50:422–33.

Article  PubMed  Google Scholar 

Crèvecoeur J, Kaminski RM, Rogister B, Foerch P, Vandenplas C, Neveux M, et al. Expression pattern of synaptic vesicle protein 2 (SV2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis. Neuropathol Appl Neurobiol. 2014;40:191–204.

Article  PubMed  Google Scholar 

Löscher W, Gillard M, Sands ZA, Kaminski RM, Klitgaard H. Synaptic vesicle glycoprotein 2A ligands in the treatment of Epilepsy and Beyond. CNS Drugs. 2016;30:1055–77.

Article  PubMed  PubMed Central  Google Scholar 

Rogawski MA. A new SV2A Ligand for Epilepsy. Cell. 2016;167:587.

Article  PubMed  Google Scholar 

Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A. 2004;101:9861–6.

Article  PubMed  PubMed Central  Google Scholar 

Chen M-K, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin S-F, et al. Assessing synaptic density in Alzheimer Disease with synaptic vesicle glycoprotein 2A Positron Emission Tomographic Imaging. JAMA Neurol. 2018;75:1215–24.

Article  PubMed  PubMed Central  Google Scholar 

Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, et al. Lower synaptic density is associated with depression severity and network alterations. Nat Commun. 2019;10:1529.

Article  PubMed  PubMed Central  Google Scholar 

Matuskey D, Tinaz S, Wilcox KC, Naganawa M, Toyonaga T, Dias M, et al. Synaptic changes in Parkinson Disease assessed with in vivo imaging. Ann Neurol. 2020;87:329–38.

Article  PubMed  PubMed Central  Google Scholar 

Finnema SJ, Nabulsi NB, Eid T, Detyniecki K, Lin S-F, Chen M-K, et al. Imaging synaptic density in the living human brain. Sci Transl Med. 2016;8:348ra96.

Article  PubMed  Google Scholar 

Finnema SJ, Toyonaga T, Detyniecki K, Chen M-K, Dias M, Wang Q, et al. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: a [11 C]UCB-J positron emission tomography study. Epilepsia. 2020;61:2183–93.

Article  PubMed  Google Scholar 

Wilke C, Worrell G, He B. Graph analysis of epileptogenic networks in human partial epilepsy. Epilepsia. 2011;52:84–93.

Article  PubMed  Google Scholar 

Gleichgerrcht E, Kocher M, Bonilha L. Connectomics and graph theory analyses: novel insights into network abnormalities in epilepsy. Epilepsia. 2015;56:1660–8.

Article  PubMed  Google Scholar 

Di X, Biswal BB, Alzheimer’s Disease Neuroimaging Initiative. Metabolic brain covariant networks as revealed by FDG-PET with reference to resting-state fMRI networks. Brain Connect. 2012;2:275–83.

Article  PubMed  PubMed Central  Google Scholar 

Yakushev I, Drzezga A, Habeck C. Metabolic connectivity: methods and applications. Curr Opin Neurol. 2017;30:677–85.

Article  PubMed  Google Scholar 

Wang M, Jiang J, Yan Z, Alberts I, Ge J, Zhang H, et al. Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia. Eur J Nucl Med Mol Imaging. 2020;47:2753–64.

Article  PubMed  PubMed Central  Google Scholar 

Zhou Y-D, Lee S, Jin Z, Wright M, Smith SEP, Anderson MP. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med. 2009;15:1208–14.

Article  PubMed  PubMed Central  Google Scholar 

Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A. 1999;96:15268–73.

Article  PubMed  PubMed Central  Google Scholar 

Venkatesan K, Alix P, Marquet A, Doupagne M, Niespodziany I, Rogister B, et al. Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice. J Neurosci Res. 2012;90:2317–27.

Article  PubMed  Google Scholar 

Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, Lopes da Silva FH, et al. Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci. 2006;26:11083–110.

Article  PubMed  PubMed Central  Google Scholar 

Yim YS, Kwon Y, Nam J, Yoon HI, Lee K, Kim DG, et al. Slitrks control excitatory and inhibitory synapse formation with LAR receptor protein tyrosine phosphatases. Proc Natl Acad Sci U S A. 2013;110:4057–62.

Article  PubMed  PubMed Central  Google Scholar 

Gomez-Castro F, Zappettini S, Pressey JC, Silva CG, Russeau M, Gervasi N, et al. Convergence of adenosine and GABA signaling for synapse stabilization during development. Science. 2021;374:eabk2055.

Article  PubMed  Google Scholar 

Takahashi H, Katayama K-I, Sohya K, Miyamoto H, Prasad T, Matsumoto Y, et al. Selective control of inhibitory synapse development by Slitrk3-PTPδ trans-synaptic interaction. Nat Neurosci. 2012;15:389–98. S1-2.

Article  PubMed  PubMed Central  Google Scholar 

Naganawa M, Li S, Nabulsi N, Henry S, Zheng M-Q, Pracitto R, et al. First-in-human evaluation of 18F-SynVesT-1, a Radioligand for PET imaging of synaptic vesicle glycoprotein 2A. J Nucl Med. 2021;62:561–7.

Article  PubMed  PubMed Central  Google Scholar 

Li S, Naganawa M, Pracitto R, Najafzadeh S, Holden D, Henry S, et al. Assessment of test-retest reproducibility of [18F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A. Eur J Nucl Med Mol Imaging. 2021;48:1327–38.

Article  PubMed